Evidence map›Paper›PMID 26367473›Full record

ArticleBehavioural brain research2016

Extended access to methamphetamine self-administration up-regulates dopamine transporter levels 72 hours after withdrawal in rats.

Christina D'Arcy, Joe E Luevano, Manuel Miranda-Arango, Joseph A Pipkin, Jonathan A Jackson, Eddie Castañeda, Kristin L Gosselink, Laura E O'Dell

Open access · greenAbstract read
In one paragraph

Article in Behavioural brain research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Christina D'ArcyDepartments of Biological Sciences, The University of Texas at El Paso, 500 West University Avenue, El Paso, TX 79968, USA.
Joe E LuevanoDepartments of Biological Sciences, The University of Texas at El Paso, 500 West University Avenue, El Paso, TX 79968, USA.
Manuel Miranda-ArangoDepartments of Biological Sciences, The University of Texas at El Paso, 500 West University Avenue, El Paso, TX 79968, USA.
Joseph A PipkinDepartments of Psychology, The University of Texas at El Paso, 500 West University Avenue, El Paso, TX 79968, USA.
Jonathan A JacksonDepartments of Psychology, The University of Texas at El Paso, 500 West University Avenue, El Paso, TX 79968, USA.
Eddie CastañedaDepartments of Psychology, The University of Texas at El Paso, 500 West University Avenue, El Paso, TX 79968, USA.
Kristin L GosselinkDepartments of Biological Sciences, The University of Texas at El Paso, 500 West University Avenue, El Paso, TX 79968, USA.
Laura E O'DellDepartments of Psychology, The University of Texas at El Paso, 500 West University Avenue, El Paso, TX 79968, USA. Electronic address: lodell@utep.edu.
The University of Texas at El Paso · US

Funding

TCCG12MD007592 · NIMHD · UNIVERSITY OF TEXAS EL PASO · PI KIRKEN, ROBERT A. · 2012 to 2018
$19.4M
Sex Differences in the Mechanisms that Promote Nicotine Reward and WithdrawalR01DA021274 · NIDA · UNIVERSITY OF TEXAS EL PASO · PI ODELL, LAURA ELENA · 2007 to 2019
$4.4M
UTEP DIDARP: Vulnerability Issues in Drug Abuse (VIDA)R24DA029989 · NIDA · UNIVERSITY OF TEXAS EL PASO · PI CASTANEDA, EDWARD · 2011 to 2015
$2.1M
Summer Mentoring And Research Training: Methods In Neuroscience of Drug-abuse (SMART-MIND)R25DA033613 · NIDA · UNIVERSITY OF TEXAS EL PASO · PI Karina C Canaba, LAURA ELENA ODELL · 2012 to 2026
$1.5M
NIDA NIH HHS R01 DA021274NIDA NIH HHS R01-DA021274NIDA NIH HHS R24 DA029989NIDA NIH HHS R24-DA029989NIDA NIH HHS R25 DA033613NIDA NIH HHS R25- DA033613NIMHD NIH HHS G12 MD007592NIMHD NIH HHS G12MD007592
6 · The paper itself

Abstract

Previous studies have demonstrated that there are persistent changes in dopamine systems following withdrawal from methamphetamine (METH). This study examined changes in striatal dopamine transporter (DAT), tyrosine hydroxylase (TH) and dopamine receptor 2 (D2) 72 h after withdrawal from METH intravenous self- administration (IVSA). Rats were given limited (1h) or extended (6h) access to METH IVSA (0.05 mg/kg/0.1 ml infusion) for 22 days. Controls did not receive METH IVSA. The rats given extended access to IVSA displayed higher METH intake during the first hour of drug access compared to rats given limited access. Extended access to METH also produced a concomitant increase in striatal DAT levels relative to drug-naïve controls. There were no changes in TH or D2 levels across groups. Previous studies have reported a decrease in striatal DAT levels during protracted periods (>7 days) of withdrawal from METH IVSA. This study extends previous work by showing an increase in striatal DAT protein expression during an earlier time point of withdrawal from this drug. These results are an important step toward understanding the dynamic changes in dopamine systems that occur during different time points of withdrawal from METH IVSA.

Indexed as

AnimalsDopamine AgentsDopamine Plasma Membrane Transport ProteinsMaleMethamphetamineNeostriatumRatsRats, WistarReceptors, Dopamine D2Time FactorsTyrosine 3-MonooxygenaseUp-RegulationDopamine AgentsDopamine Plasma Membrane Transport ProteinsMethamphetamineReceptors, Dopamine D2Tyrosine 3-MonooxygenaseAbstinenceDopamine transporterIVSAMethamphetamineStriatumWithdrawal

Identifiers

PMID26367473
PMCPMC4659727
OpenAlexW1822644108

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.